192 Additionally, mRNA therapy has been applied to treat patients with deficiencies in essential enzyme genes, such as argininosuccinate lyase, ornithine transcarbamylase, and methylmalonyl-CoA mutase (MUT), therefore restoring enzyme levels and mitigating deficiencies
Microdosing in the GLP-1 context typically means starting below the labeled dose or extending titration intervals
Topiramate affords neuroprotection in diabetic neuropathy model via downregulating spinal GFAP/inflammatory burden and improving neurofilament production
Conclusion: Building Cellular Resilience for the Long Game Women's longevity is not about surviving longer
Diabetes, metabolic syndrome and obesity: targets and therapy 11726 Anson M, Zhao SS, Austin P, Ibarburu GH, Malik RA, Alam U (2023) SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
Diabetes mellitus as a risk factor for depression